Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 1.Overview of EGFR-Mutant Advanced NSCLC

EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians

Now Viewing

EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC

EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC

EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective

EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab

EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC

EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey

EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC

Video content above is prompted by the following:

• What is the typical approach to coordination of care for patients with lung cancer at your institution?
• Which healthcare professionals are typically involved?
• How are their efforts coordinated to optimize the patient journey, from diagnosis through treatment and follow-up?
• Describe your role as a nurse in the multidisciplinary treatment of advanced breast cancer.
• Upon referral, what were your thoughts when considering your treatment options?
• What questions or concerns did you have for him and his care team?
• What specific worries or anxieties were at the forefront of your mind?
• Once Melinda was referred to your office, what steps did you take to evaluate and confirm diagnosis of EGFR-mutant NSCLC?